Latest News & Features
.jpg/r%5Bwidth%5D=1280&r%5Bheight%5D=720/805eb780-39f0-11ef-ae3b-39eca959fd5a-Shutterstock_1991562455%20(2).webp)
Europe
UK leg of global litigation over mRNA tech sees patents ruled valid and invalid | Justice Meade follows EPO in decision on Moderna’s EP 565 patent | Pfizer and German partner BioNTech on the hook for EP 949 | Opinion on Moderna’s COVID pledge also handed down. 4 July 2024
Careers
New partner has expertise across life sciences, biotech and medtech | Patent attorney spent over 15 years at Knobbe Martens. 4 July 2024
Americas
Biomodal claims New England Biolabs infringed eight patents licensed by US non-profit | Cambridge-based firm produces ‘duet platform’ encompassing genetics and epigenetics. 4 July 2024
Americas
List compiled by sister title features peer-reviewed IP lawyers from across six continents | 2024 edition “most comprehensive and rigorous” to date, says rankings editor | Data reveals gender ratio and practice area concentration by continent. 2 July 2024
Americas
As SCOTUS pulls away from deference to federal agencies, issues such as non-competes and terminal disclaimers could be on shaky ground, finds Muireann Bolger. 2 July 2024
Europe
Double promotion includes patent attorney who challenged Novartis in G1/22 | Supplementary Protection Certificates expert also joins partnership. 2 July 2024
Big Pharma
Clarivate analysis identifies 140,000 patented inventions in digital health in decade to 2022 | Patentees comprise a ‘surprising mix’ of companies across various industries. 2 July 2024
Europe
In its first year, uptake of cases at the Unified Patent Court has surpassed most expectations. Darren Smyth of EIP delves into the facts and figures behind the headlines, with some surprising results. 27 June 2024
Americas
Womble Bond Dickinson’s new South Carolina partner previously led Dority & Manning’s chemical and life sciences group. 27 June 2024
Americas
Judges considered Hikma’s label and marketing material when overturning lower court’s decision | Court said Amarin had stated plausible claim for induced infringement of patents. 27 June 2024